array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(24) "Idexx Laboratories, Inc."
["slug"]=>
string(31) "52dfe-us-idexx-laboratories-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/adce9a3c-023b-4043-9c56-fbed7dab6f62"
["description"]=>
string(1658) "10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock
We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries.
Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices.
We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk.
Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities."
["address_street"]=>
string(10) "1 Idexx Dr"
["address_place"]=>
string(9) "Westbrook"
["address_region"]=>
string(5) "Maine"
["founding_date"]=>
string(10) "1983-02-28"
["website_domain"]=>
string(9) "idexx.com"
["website_url"]=>
string(21) "https://www.idexx.com"
["industry_codes"]=>
array(4) {
[0]=>
string(43) "General Livestock, Except Dairy and Poultry"
[1]=>
string(33) "Veterinary Services for Livestock"
[2]=>
string(27) "Pharmaceutical Preparations"
[3]=>
string(42) "In Vitro and In Vivo Diagnostic Substances"
}
["employee_count"]=>
int(710)
["article_count"]=>
int(641)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(66) "IDEXX Laboratories to Release 2024 First Quarter Financial Results"
["snippet_en"]=>
string(233) "WESTBROOK, Maine, April 04, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 first quarter results for Wednesday, May 1, 2024, before the market opens."
["url"]=>
string(90) "https://es-us.finanzas.yahoo.com/news/idexx-laboratories-release-2024-first-203000755.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/05f95f58-f430-4b50-a78f-c08f08e16130"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2024-04-04"
["categories"]=>
array(3) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(14) "Product Launch"
[2]=>
string(24) "Quarterly/Annual Figures"
}
}
[1]=>
array(7) {
["title_en"]=>
string(124) "IDEXX Launches VelloTM, an Innovative Pet Owner Engagement Software Solution, Streamlining How Practices and Clients Connect"
["snippet_en"]=>
string(154) "/CNW/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announces the launch of Vello, a software solution that..."
["url"]=>
string(176) "https://www.newswire.ca/news-releases/idexx-launches-vello-tm-an-innovative-pet-owner-engagement-software-solution-streamlining-how-practices-and-clients-connect-800224834.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/32b45b3f-9586-48f7-9ae1-eb7f57482a6e"
["source"]=>
string(11) "newswire.ca"
["publication_date"]=>
string(10) "2024-02-15"
["categories"]=>
array(2) {
[0]=>
string(14) "Product Launch"
[1]=>
string(10) "New Market"
}
}
[2]=>
array(7) {
["title_en"]=>
string(65) "IDEXX Laboratories (IDXX) to Release Quarterly Earnings on Monday"
["snippet_en"]=>
string(204) "IDEXX Laboratories (NASDAQ:IDXX) will be releasing earnings before the market opens on Monday, February 5, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=259264)"
["url"]=>
string(79) "https://www.marketbeat.com/instant-alerts/nasdaq-idxx-earnings-date-2024-01-29/"
["image_url"]=>
NULL
["source"]=>
string(14) "marketbeat.com"
["publication_date"]=>
string(10) "2024-01-29"
["categories"]=>
array(4) {
[0]=>
string(14) "Product Launch"
[1]=>
string(15) "Market Movement"
[2]=>
string(5) "Event"
[3]=>
string(24) "Quarterly/Annual Figures"
}
}
[3]=>
array(7) {
["title_en"]=>
string(56) "IDEXX unveils AI-based cellular analyzer for vet clinics"
["snippet_en"]=>
string(56) "IDEXX unveils AI-based cellular analyzer for vet clinics"
["url"]=>
string(116) "https://uk.investing.com/news/stock-market-news/idexx-unveils-aibased-cellular-analyzer-for-vet-clinics-93CH-3296904"
["image_url"]=>
NULL
["source"]=>
string(13) "investing.com"
["publication_date"]=>
string(10) "2024-01-12"
["categories"]=>
array(1) {
[0]=>
string(14) "Product Launch"
}
}
[4]=>
array(7) {
["title_en"]=>
string(67) "IDEXX Laboratories to Release 2023 Second Quarter Financial Results"
["snippet_en"]=>
string(233) "WESTBROOK, Maine, June 29, 2023--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 second quarter results for Tuesday, August 1, 2023 before the market opens."
["url"]=>
string(87) "https://nz.finance.yahoo.com/news/idexx-laboratories-release-2023-second-190000328.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/1a30ffa7-efd4-47ec-b346-b6eb87c1d468"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2023-06-29"
["categories"]=>
array(3) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(14) "Product Launch"
[2]=>
string(24) "Quarterly/Annual Figures"
}
}
[5]=>
array(7) {
["title_en"]=>
string(54) "IDEXX (IDXX) Launches First Veterinary Diagnostic Test"
["snippet_en"]=>
string(165) "IDEXX (IDEXX) Cystatin B Test can help veterinary professionals to spot kidney damage before it affects kidney function, which may result in better patient outcomes."
["url"]=>
string(82) "https://finance.yahoo.com/news/idexx-idxx-launches-first-veterinary-124200644.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/468db132-be8d-47b7-9744-a0a9196c02ad"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2023-06-16"
["categories"]=>
array(4) {
[0]=>
string(18) "Ecological Impacts"
[1]=>
string(41) "E-commerce and Technological Developments"
[2]=>
string(37) "Product Design & Lifecycle Management"
[3]=>
string(14) "Product Launch"
}
}
[6]=>
array(7) {
["title_en"]=>
string(66) "IDEXX Laboratories to Release 2023 First Quarter Financial Results"
["snippet_en"]=>
string(265) "13.04.2023 - IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 first quarter results for Tuesday, May 2, 2023 before the market opens. The Company will conduct an analyst conference call ..."
["url"]=>
string(118) "https://www.wallstreet-online.de/nachricht/16799747-idexx-laboratories-to-release-2023-first-quarter-financial-results"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/d3ae3200-07a1-44a7-bbab-b2ec617cb7a2"
["source"]=>
string(20) "wallstreet-online.de"
["publication_date"]=>
string(10) "2023-04-13"
["categories"]=>
array(2) {
[0]=>
string(14) "Product Launch"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
[7]=>
array(7) {
["title_en"]=>
string(124) "IDEXX Innovative Diagnostic and Software Solutions Provide Workflow Efficiency and Faster, More Confident Clinical Decisions"
["snippet_en"]=>
string(153) "/PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announced today a series of product and service..."
["url"]=>
string(179) "https://www.prnewswire.com/news-releases/idexx-innovative-diagnostic-and-software-solutions-provide-workflow-efficiency-and-faster-more-confident-clinical-decisions-301459620.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/bb41d721-67ea-4573-b408-b672fcca35b8"
["source"]=>
string(14) "prnewswire.com"
["publication_date"]=>
string(10) "2022-01-13"
["categories"]=>
array(3) {
[0]=>
string(37) "Product Design & Lifecycle Management"
[1]=>
string(5) "R & D"
[2]=>
string(14) "Product Launch"
}
}
[8]=>
array(7) {
["title_en"]=>
string(81) "IDEXX launches its first point-of-care bovine pregnancy test for cattle producers"
["snippet_en"]=>
string(156) "IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, announces a new whole blood, on-farm, pregnancy test for bovine animals."
["url"]=>
string(119) "https://hoards.com/article-31200-idexx-launches-its-first-point-of-care-bovine-pregnancy-test-for-cattle-producers.html"
["image_url"]=>
NULL
["source"]=>
string(10) "hoards.com"
["publication_date"]=>
string(10) "2021-11-29"
["categories"]=>
array(2) {
[0]=>
string(14) "Product Launch"
[1]=>
string(10) "New Market"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(117)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(65)
}
[2]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(43)
}
[3]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(43)
}
[4]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(40)
}
[5]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(24)
}
[6]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(22)
}
[7]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(22)
}
[8]=>
array(2) {
["name"]=>
string(12) "Restatements"
["count"]=>
int(21)
}
[9]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(19)
}
[10]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(18)
}
[11]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(16)
}
[12]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(14)
}
[13]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(12)
}
[14]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(9)
}
[15]=>
array(2) {
["name"]=>
string(9) "Investors"
["count"]=>
int(9)
}
[16]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(8)
}
[17]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(8)
}
[18]=>
array(2) {
["name"]=>
string(16) "Share Repurchase"
["count"]=>
int(7)
}
[19]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(7)
}
[20]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(7)
}
[21]=>
array(2) {
["name"]=>
string(31) "Water and Wastewater Management"
["count"]=>
int(7)
}
[22]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(7)
}
[23]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(6)
}
[24]=>
array(2) {
["name"]=>
string(15) "Blogs & Columns"
["count"]=>
int(6)
}
[25]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(5)
}
[27]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(5)
}
[28]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(5)
}
[29]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(5)
}
}
}
52dfe-us-idexx-laboratories-inc
Idexx Laboratories, Inc.
Location
Maine
Founded
1983-02-28
Website
https://www.idexx.com
Articles
641 Articles
Category
General Livestock, Except Dairy and Poultry
Veterinary Services for Livestock
Pharmaceutical Preparations
In Vitro and In Vivo Diagnostic Substances
Description
10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock
We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries.
Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices.
We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk.
Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities.
WESTBROOK, Maine, April 04, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 first quarter results for Wednesday, May 1, 2024, before the market opens.
/CNW/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announces the launch of Vello, a software solution that...
IDEXX Laboratories (NASDAQ:IDXX) will be releasing earnings before the market opens on Monday, February 5, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=259264)
WESTBROOK, Maine, June 29, 2023--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 second quarter results for Tuesday, August 1, 2023 before the market opens.
IDEXX (IDEXX) Cystatin B Test can help veterinary professionals to spot kidney damage before it affects kidney function, which may result in better patient outcomes.
13.04.2023 - IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 first quarter results for Tuesday, May 2, 2023 before the market opens. The Company will conduct an analyst conference call ...
/PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announced today a series of product and service...
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, announces a new whole blood, on-farm, pregnancy test for bovine animals.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.